1 Min Read
March 8 (Reuters) - Lupin Ltd:
* SIGNS AGREEMENT WITH CSIR-NCL AND DST FOR DEVELOPMENT OF CONTINUOUS MANUFACTURING PROCESS FOR BIOSIMILAR MONOCLONAL ANTIBODY THERAPEUTIC Source text: bit.ly/2tuFC1Q Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.